Ravata Solutions has been awarded a National Institute of Health (NIH) Phase 1 SBIR. The company’s cutting edge utilization of microfluidic automation, a proven sensing platform microfabricated for embryos, and proprietary embryo datasets for AI development set it apart when determining the embryo most likely to induce a pregnancy. Read the article >